Results 171 to 180 of about 2,529,224 (293)

Development of a Nomogram‐Based Clinical Estimation Model for Pathological Upstaging in Patients With Preoperative Ductal Carcinoma In Situ

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Preoperative diagnosis of ductal carcinoma in situ (DCIS) may be followed by pathological upstaging to invasive ductal carcinoma (IDC) upon surgical excision, a discrepancy that significantly impacts surgical planning and decisions regarding sentinel lymph node biopsy (SLNB).
Yu‐Hua Chen, Chung‐Liang Li, Ping‐Fu Yang, Hui‐Hua Hsiao, Fang‐Ming Chen, Sin‐Hua Moi   +5 more
wiley   +1 more source

Deep infiltrating endometriosis presenting as acute abdomen with extremely elevated tumor markers: a cancer-mimicking case. [PDF]

BMC Womens Health
Ma X, Ye JS, Liu Z, Geng QL.
europepmc   +1 more source

Disulfidptosis‐ and Ferroptosis‐Related Gene Signatures in Rheumatoid Arthritis: Association Analysis and Diagnostic Model Construction

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation and progressive joint damage. Although ferroptosis has been implicated in RA progression, the role of disulfidptosis and its interaction with ferroptosis remains unclear.
Ting‐Ting Wang, Dong‐Mei Wang, Xue Li, Yuan‐Li Wei, Ping‐Dan Liu, Shi‐Lin Li, Si‐Ying Xiong, Cai‐Zhen Liu, Fan‐Xin Zeng, Jian‐Hong Wu, Lin Tang   +10 more
wiley   +1 more source

Molecular Response Assessment From Circulating Tumor DNA in Patients With Ovarian Cancer Treated With the WEE1 Inhibitor Azenosertib. [PDF]

JCO Precis Oncol
Jeong J, Ma J, Abed M, Chung H, Kim D, Molden N, Rajendran D, Shim C, Jandial DD, Simpkins F, Meric-Bernstam F, Randall LM, Lackner MR, Harismendy O.   +13 more
europepmc   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source

Can semaglutide influence tumor biomarkers? Insight from a clinical case. [PDF]

J Food Drug Anal
Schianchi A, Mauri F, Polli C.
europepmc   +1 more source

Analysis of Carbohydrates and Glycoconjugates by Matrix‐Assisted Laser Desorption/Ionization Mass Spectrometry: An Update for 2023–2024

Mass Spectrometry Reviews, EarlyView.
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley   +1 more source

Serum biomarkers associated with disease stage and pain severity among women with endometriosis in Indonesia. [PDF]

Narra J
Mustaqin M, Rajuddin R, Dewi TP, Yeni CM, Rusnaidi R, Suhanda R.   +5 more
europepmc   +1 more source

Toxicity Differences Between Microplastics and Nanoplastics in Organs: From Molecular Mechanisms to Potential Therapeutic Strategies

Med Research, EarlyView.
This review systematically compares the size‐dependent toxicity of microplastics and nanoplastics in the intestine, liver, kidney, lung, and brain. Particle size determines bioavailability, barrier penetration, and injury mechanisms. Because of their small size and high surface reactivity, NPs readily cross the intestinal epithelium and blood–brain ...
Yixian Cheng, Junjie Chen, Rui Fu, Jiawei Zhang, Jianguang Jia, Wei Wang, Zheng Zhang, Peng Zhang, Haosong Chen, Huake Cao, Gang Li, Weiwei Sheng, Ting Li, Bo Chen, Guodong Cao   +14 more
wiley   +1 more source

Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer. [PDF]

Cancer Epidemiol Biomarkers Prev
McGann KC, Woodhouse P, Chen H, Kammer MN, Holmes HM, Lopez C, Pass HI, Tsay JJ, Lenburg ME, Dubinett SM, Willey JC, Herman JG, Schabath MB, Khalil TA, Zou Y, Potter MH, Chen SC, Argaw SA, Meyers P, Fischer S, Tran C, Forero YJ, Antic S, Paez R, Lila E, Barón AE, Maldonado F, Deppen SA, Grogan EL.   +28 more
europepmc   +1 more source